Atlas Trials

Jiangsu Yahong Meditech Co., Ltd aka Asieris

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jiangsu Yahong Meditech Co., Ltd aka Asieris

RecordFirmDate
Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors (NCT06787950)Jiangsu Yahong Meditech Co., Ltd aka Asieris2025-02-20
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers (NCT06034015)Jiangsu Yahong Meditech Co., Ltd aka Asieris2023-09-09
A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis (NCT05743010)Jiangsu Yahong Meditech Co., Ltd aka Asieris2023-01-26
A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (NCT04813107)Jiangsu Yahong Meditech Co., Ltd aka Asieris2021-12-28
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (NCT04736394)Jiangsu Yahong Meditech Co., Ltd aka Asieris2021-09-29

Track Jiangsu Yahong Meditech Co., Ltd aka Asieris automatically

Every clearance here is in the API, with alerts when new ones post.